Interleukin-6 treatment enhances human monocyte permissiveness for Paracoccidioides brasiliensis growth by modulating cytokine production

References

• Fromtling RA, Shadomy HJ. An overview of macrophage-fungal interactions. Mycopathologia 1986; 93: 77–93
   PubMed Web of Science ®Google Scholar
• Gordon S. The role of the macrophage in immune regulation. Res Immunol 1998; 149: 685–688
   PubMedGoogle Scholar
• Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008; 13: 453–461
   PubMed Web of Science ®Google Scholar
• Zhang X, Mosser DM. Macrophage activation by endogenous danger signals. J Pathol 2008; 214: 161–178
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr Opin Immunol 1997; 9: 17–23
   PubMedGoogle Scholar
• Reed SG. TGF-beta in infections and infectious diseases. Microbes Infect 1999; 1: 1313–1325
   PubMed Web of Science ®Google Scholar
• Sadeghi HM, Schnelle JF, Thomas JK, Nishanian P, Fahey JL. Phenotypic and funtional characteristics of circulating monocytes of elderly persons. Exp Gerontology 1999; 34: 959–970
   PubMed Web of Science ®Google Scholar
• Lin PL, Plessner HL, Voitenok NN, Flynn JL. Tumor necrosis factor and tuberculosis. J Investig Dermatol Symp Proc 2007; 12: 22–25
   PubMed Web of Science ®Google Scholar
• Hamblin AS. Cytokines and Cytokine Receptors. Oxford: University Press, 1993.
   Google Scholar
• Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 1988; 334: 260–262
   PubMed Web of Science ®Google Scholar
• Van Furth R. Human monocytes and cytokines. Res Immunol 1998; 149: 719–720
   PubMedGoogle Scholar
• Dooley DP, Cox RA, Hestilow KL, Dolan MJ, Magee DM. Cytokine induction in human coccidioidomycosis. Infect Immun 1994; 62: 3980–3983
   PubMedGoogle Scholar
• Vecchiarelli A, Retini C, Pietrella D, et al. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun 1995; 63: 2919–2923
   PubMed Web of Science ®Google Scholar
• Xiong J, Kang K, Liu L, et al. Candida albicans and Candida krusei differentially induce human blood mononuclear cell interleukin-12 and gamma interferon production. Infect Immun 2000; 68: 2464–2469
   PubMedGoogle Scholar
• Kesavan S, Walters CE, Holland KT, Ingham E. The effects of Malassezia on pro-inflammatory cytokine production by human peripheral blood mononuclear cells in vitro. Med Mycol 1998; 36: 97–106
   PubMed Web of Science ®Google Scholar
• Suzuki T, Tsuzuki A, Ohno N, Ohshima Y, Yadomae T. Enhancement of IL-8 production from human monocytic and granulocytic cell lines, THP-1 and HL-60, stimulated with Malassezia, furfur. FEMS Immunol Med Microbiol 2000; 28: 157–162
   Google Scholar
• Calvi SA, Peraçoli MT, Mendes RP, et al. Effect of cytokines on the in vitro fungicidal activity of monocytes from paracoccidioidomycosis patients. Microbes Infect 2003; 5: 107–113
   PubMed Web of Science ®Google Scholar
• Delfino D, Cianci L, Migliardo M, et al. Tumor necrosis factor-inducing activities of Cryptococcus neoformans components. Infect Immun 1996; 64: 5199–5204
   PubMed Web of Science ®Google Scholar
• Delfino D, Cianci L, Lupis E, et al. Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components. Infect Immun 1997; 65: 2454–2456
   PubMed Web of Science ®Google Scholar
• Levitz SM, Tabuni A, Kornfeld H, Reardon CC, Golenbock DT. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun 1994; 62: 1975–1981
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A, Retini C, Monari C, et al. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect Immun 1996; 64: 2846–2849
   PubMedGoogle Scholar
• Raponi G, Ghezzi MC, Mancini C, Filadoro F. Preincubation of Candida albicans strains with amphotericin B reduces tumor necrosis factor alpha and interleukin-6 release by human monocytes. Antimicrob Agents Chemother 1993; 37: 1958–1961
   PubMed Web of Science ®Google Scholar
• Cox RA, Magee DM. Production of tumor necrosis factor alpha, interleukin-1 alpha, and interleukin-6 during murine coccidioidomycosis. Infect Immun 1995; 63: 4178–4180
   PubMed Web of Science ®Google Scholar
• Peraçoli MT, Kurokawa CS, Calvi SA, et al. Production of pro- and anti-inflammatory cytokines by monocytes from patients with paracoccidioidomycosis. Microbes Infect 2003; 5: 413–418
   PubMed Web of Science ®Google Scholar
• Silva CL, Silva MF, Faccioli LH, et al. Differential correlation between interleukin patterns in disseminated and chonic human paracoccidioidomycosis. Clin Exp Immunol 1995; 101: 314–320
   PubMed Web of Science ®Google Scholar
• Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993; 54: 1–78
   PubMed Web of Science ®Google Scholar
• Bermudez LE, Wu M, Petrofsky M, Young LS. Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Infect Immun 1992; 60: 4245–4252
   PubMed Web of Science ®Google Scholar
• Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990; 144: 480–484
   PubMed Web of Science ®Google Scholar
• Denis M, Gregg EO, Ghandirian E. Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages. Int J Immunopharmacol 1990; 12: 721–727
   PubMed Web of Science ®Google Scholar
• Denis M, Gregg EO. Recombinant interleukin-6 increases the intracellular and extracellular growth of Mycobacterium avium. Can J Microbiol 1991; 37: 479–483
   Google Scholar
• Franco M, Mendes RP, Moscardi-Bacchi M, Rezkallah-Iwasso MT, Montenegro MR. Paracoccidioidomycosis. Bailliere's Clin Trop Med Comm Dis 1989; 4: 185–220
   Google Scholar
• Kurokawa CS, Araujo JP, Soares AM, Sugizaki MF, Peraçoli MT. Pro- and anti-Inflammatory cytokines produced by human monocytes challenged in vitro with Paracoccidioides brasiliensis. Microbiol Immunol 2007; 51: 421–428
   PubMedGoogle Scholar
• Peraçoli MTS, Sugizaki MF, Mendes RP, Naiff R, Montenegro MR. Paracoccidioides brasiliensis isolated from armadillos is virulent to syrian hamsters. Mycopathol 1999; 148: 123–130
   PubMedGoogle Scholar
• Soares AM, Calvi SA, Peracoli MT, et al. Modulatory effect of prostaglandins on human monocyte activation for killing of high- and low-virulence strains of Paracoccidioides brasiliensis. Immunology 2001; 102: 480–485
   PubMed Web of Science ®Google Scholar
• Li CY, Lam KW, Yam LT. Esterases in human leukocytes. J Histochem Cytochem 1973; 21: 1–12
   PubMed Web of Science ®Google Scholar
• Singer-Vermes LM, Ciavaglia MC, Kashino SS, Burger E, Calich VL. The source of the growth-promoting factor(s) affects the plating efficiency of Paracoccidioides brasiliensis. J Med Vet Mycol 1992; 30: 261–264
   PubMedGoogle Scholar
• Blanchard DK, Michelini-Norris MB, Pearson CA, Freitag CS, Djeu JY. Mycobacterium avium-intracellulare induces interleukin-6 from human monocytes and large granular lymphocytes. Blood 1991; 77: 2218–2224
   Google Scholar
• Denis M. Growth of Mycobacterium avium in human monocytes: identification of cytokines which reduce and enhance intracellular microbial growth. Eur J Immunol 1991; 21: 319–395
   Google Scholar
• Denis M, Gregg EO. Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages. Immunology 1990; 71: 139–141
   PubMed Web of Science ®Google Scholar
• Denis M. Interleukin-6 is used as a growth factor by virulent Mycobacterium avium: presence of specific receptors. Cell Immunol 1992; 141: 182–188
   Google Scholar
• Tamandl D, Bahami M, Wessner B, et al. Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness whereas interleukin-6 enhances lipopolysaccharide activity. Shock 2003; 20: 224–229
   PubMed Web of Science ®Google Scholar
• Levitz SM. Interactions of Toll-like receptors with fungi. Microbes Infect 2004; 6: 1351–1355
   PubMed Web of Science ®Google Scholar
• Roeder A, Kirschning CJ, Rupec RA, Schaller M, Korting HC. Toll-like receptors and innate antifungal responses. Trends Microbiol 2004; 12: 44–49
   PubMed Web of Science ®Google Scholar
• Roeder A, Kirschning CJ, Rupec RA, et al. Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 2004; 42: 485–498
   PubMed Web of Science ®Google Scholar
• Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002; 168: 554–561
   PubMed Web of Science ®Google Scholar
• Paul R, Koedel U, Winkler F, et al. Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain 2003; 126: 1873–1882
   PubMed Web of Science ®Google Scholar
• Schindler R, Mancilla J, Endres S, et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1 and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990; 75: 40–47
   PubMed Web of Science ®Google Scholar
• Figueiredo F, Alves LM, Silva CL. Tumor necrosis factor production in vivo and in vitro in response to Paracoccidioides brasiliensis and the cell wall fractions thereof. Clin Exp Immunol 1993; 93: 189–194
   PubMed Web of Science ®Google Scholar
• Parise-Fortes MR, Da Silva MF, Sugizaki MF, et al. Experimental paracoccidioidomycosis of the Syrian hamster: fungicidal activity and production of inflammatory cytokines by macrophages. Med Mycol 2000; 38: 51–60
   PubMed Web of Science ®Google Scholar
• Langermans JA, Van Der Hulst ME, Nibbering PH, Van Furth R. Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice. Infect Immun 1992; 60: 5107–5112
   Google Scholar
• Green SJ, Crawford RM, Hockmeyer JT, Meltzer MS, Nacy CA. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol 1990; 145: 4290–4297
   PubMed Web of Science ®Google Scholar
• Reiner NE, Ng W, Wilson CB, McMaster WR, Burchett SK. Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition to interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin-1. J Clin Invest 1990; 85: 1914–1924
   Google Scholar
• Wu-Hsieh BA, Lee GS, Franco M, Hofman FM. Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect Immun 1992; 60: 4230–4238
   PubMedGoogle Scholar
• Beaman L. Effects of recombinant gamma interferon and tumor necrosis factor on in vitro interactions of human mononuclear phagocytes with Coccidioides immitis. Infect Immun 1991; 59: 4227–4229
   Google Scholar
• Carmo JPM, Dias-Melicio LA, Calvi SA, Peracoli MT, Soares AM. TNF-alpha activates human monocytes for Paracoccidioides brasiliensis killing by an H2O2-dependent mechanism. Med Mycol 2006; 44: 363–368
   PubMed Web of Science ®Google Scholar
• Levitz SM, Tabuni A, Nong SH, Golenbock DT. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect Immun 1996; 64: 945–951
   PubMed Web of Science ®Google Scholar
• Redpath S, Ghazal P, Gascoigne NRJ. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol 2001; 9: 86–92
   PubMed Web of Science ®Google Scholar
• Fornari MC, Bava AJ, Guereno MT, et al. High serum interleukin-10 and tumor necrosis factor alpha levels in chronic paracoccidioidomycosis. Clin Diagn Lab Immunol 2001; 8: 1036–1038
   Google Scholar
• Benard G, Romano CC, Cacere CR, et al. AJS. Imbalance of IL-2, IFN-γ and IL-10 secretion in the immunosuppression associated with human paracoccidioidomycosis. Cytokine 2001; 13: 248–252
   PubMed Web of Science ®Google Scholar
• Oliveira SJ, Mamoni RL, Mustti CC, Papaiordanou PMO, Blotta MHSL. Cytokines and lymphocyte proliferation in juvenile and adult forms of paracoccidioidomycosis: comparision with infected and non-infected controls. Microbes Infect 2002; 4: 139–144
   PubMed Web of Science ®Google Scholar
• Peracoli MTS, Kurokawa CS, Calvi SA, et al. Production of pro- and anti-inflammatory cytokines by monocytes from patients with paracoccidioidomycosis. Microbes Infect 2003; 5: 413–418
   PubMed Web of Science ®Google Scholar
• Calich VLG, Kashino SS. Cytokines produced by susceptible and resistant mice in the course of Paracoccidioides brasiliensis infection. Braz J Med Biol Res 1998; 31: 615–623
   PubMed Web of Science ®Google Scholar
• Soares AMVC, Silva, WB, Rodrigues, DR. IL-10 but not TGF-β inhibits Paracoccidioides brasiliensis killing by human activated monocytes. Ann Rev Biom Sci 2002; Suppl: 89–89.
   Google Scholar
• De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209–1220
   PubMed Web of Science ®Google Scholar
• Jablons DM, Mule JJ, McIntosh JK, et al. IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans. J Immunol 1989; 142: 1542–1547
   PubMed Web of Science ®Google Scholar
• Havell EA, Sehgal PB. Tumor necrosis factor-independent IL-6 production during murine listeriosis. J Immunol 1991; 146: 756–761
   PubMed Web of Science ®Google Scholar
• Kontny E, Ziolkowska M, Maslinski W. Production of pro-inflammatory cytokines in human monocytes: not a cascade but the dependence on protein kinase C pathway. Immunol Lett 1999; 67: 263–267
   Google Scholar